Search

Aim: Conventional surgical management of colovesical and colovaginal fistulas can be morbid and is contraindicated in many patients. Our aim in this work is to evaluate our experience in the management of colovesical and colovaginal fistulas with endoscopic over‐the‐scope (OTS) clips. Method: A retrospective review of all patients who underwent attempted endoscopic OTS clip management of colovesical and colovaginal fistulas between 2013 and 2020 was performed. Preoperative risk factors, operative details and postoperative outcomes are reported. Results: Ten patients were identified. Fistula types were: colovesical (five), rectovesical (two), colovaginal (two) and rectovaginal (one). The aetiology of the fistula was diverticular disease in seven (70%) cases and surgical complication of pelvic surgery in three (30%). The mean defect age was 157 ± 98 days, the mean defect diameter was 4.5 mm (range 2–10 mm) and the mean fistula length was 15 mm (range 2–25 mm). In nine (90%) cases, fistula identification and cannulation were performed through the nonenteric lumen of the fistula. Initial management with an OTS clip was technically successful in eight (80%) patients. Of the eight patients who underwent OTS clip placement, long‐term success (mean follow‐up 218 days, range 25–673 days) was achieved after initial intervention in four (50%) patients. One patient underwent serial OTS clip procedures and achieved long‐term success after four interventions; three patients have not undergone a repeat procedure after initial failure. Conclusion: Endoscopic management of colovesical and colovaginal fistulas with OTS clips offers a promising therapeutic option for patients with contraindications to conventional surgical management. Immediate technical success and long‐term success rates are similar to other gastrointestinal tract applications of OTS clips. [ABSTRACT FROM AUTHOR]

The article presents a study which evaluates the Stanford Online Calculator (SOC) designed to predict the likelihood of nonsentinel lymph node (NSLN) metastasis. Results of the study show that the mean SOC probabilities for patients with NSLN metastasis was 0.75 while .50 for those without NSLN metastasis. Researchers conclude that the Stanford nomogram seems to have performed on a par with despite the use of only three variables.